FcγRIIb deficiency inhibits tumor development by attenuating the immunosuppressive phenotype of MDSCs
Immunology Letters · 2026-08 · 280 · 107177
DOI: 10.1016/j.imlet.2026.107177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology Letters, 2026-08. Verfasst von Wenyan Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of the Jiangsu Higher Education Institutions for Nucleic Acid & Cell Fate Regulation (Yangzhou University), Institute of Translational…. Hauptthemen laut MEDLINE: Receptors, IgG, Myeloid-Derived Suppressor Cells, Lung Neoplasms. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Graduate Research and Innovation Projects of Jiangsu Province.
Abstract (Originalsprache)
Regulation of myeloid-derived suppressor cell (MDSC) programming is critical for controlling tumor growth and anti-tumor immune responses. The role of FcγRIIb in MDSC programming was examined. FcγRIIb deficiency was found to promote MDSC differentiation and increase splenic MDSC accumulation in tumor-bearing mice. This deficiency also attenuated the immunosuppressive phenotype of both polymorphonuclear (PMN)-MDSCs and monocytic (M)-MDSCs. Tumor growth in FcγRIIb-/- mice was significantly lower than in wild-type (WT) mice. Adoptive transfer of FcγRIIb-/- MDSC subsets following B16F10/3LL injection significantly delayed tumor growth compared with transfer of WT MDSC subsets. Activation of the NF-κB pathway was observed in FcγRIIb-/- MDSCs, which was associated with the diminished immunosuppressive phenotype. In human MDSCs, FcγRIIb expression was associated with the progression of lung cancer. These findings demonstrate that FcγRIIb is crucial for the immunosuppressive phenotype of MDSCs and may serve as a potential therapeutic target for anti-tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of the Jiangsu Higher Education Institutions for Nucleic Acid & Cell Fate Regulation (Yangzhou University), Institute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou, 225001,…
- Department of Respiratory Medicine, Taizhou Second People's Hospital Affiliated to Yangzhou University, Yangzhou University, Yangzhou, PR 225001, PR China.
- Department of Ophthalmology, the Affiliated Hospital of Yangzhou University, Yangzhou, 225001, PR China. Electronic address: zhuxiaoyu@yzu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Graduate Research and Innovation Projects of Jiangsu Province
Zitieren
APA
Chen, W., Pan, J., Ning, X., Li, D., Shen, T., Cai, L., Wang, S., Qian, L., & Zhu, X. (2026). FcγRIIb deficiency inhibits tumor development by attenuating the immunosuppressive phenotype of MDSCs. Immunology Letters, 280, 107177. https://doi.org/10.1016/j.imlet.2026.107177
Vancouver
Chen W, Pan J, Ning X, Li D, Shen T, Cai L, et al. FcγRIIb deficiency inhibits tumor development by attenuating the immunosuppressive phenotype of MDSCs. Immunology Letters. 2026;280:107177. doi:10.1016/j.imlet.2026.107177
BibTeX
@article{Chen2026,
author = {Chen, Wenyan and Pan, JiaHua and Ning, Xiaomin and Li, Dongkun and Shen, Tingting and Cai, Liangliang and Wang, Shaoqing and Qian, Li and Zhu, Xiaoyu},
title = {FcγRIIb deficiency inhibits tumor development by attenuating the immunosuppressive phenotype of MDSCs},
journal = {Immunology Letters},
year = {2026},
volume = {280},
pages = {107177},
doi = {10.1016/j.imlet.2026.107177}
}
EUVIMED